Greenline Partners’s CONMED CNMD Stock Holding History

Greenline Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	-$60	–	224
2025 Q1	$60	Buy	+1	New	+$64	﹤0.01%	576

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Greenline Partners's CNMD Position: Q2 2025 in Review

Greenline Partners sold out of CONMED (CNMD) in Q2 2025, closing a stake of 1 share — an estimated $60 sold.

Greenline Partners first reported a position in CNMD in Q1 2025 and held it in 1 quarter. The position peaked at $60 in Q1 2025. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

Greenline Partners reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
Greenline Partners sold 1 CONMED share in Q2 2025, an estimated $60.
Greenline Partners first reported a position in CONMED in Q1 2025 and held it in 1 quarter.
Greenline Partners's CONMED position peaked at $60 in Q1 2025.
276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Greenline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.